References
- Parkin DM, Pisani P, Ferlay J. Global cancer statistics. Ca Cancer. J Clinic 1999; 49: 33–64.
- Midgley R, Kerr D. Colorectal cancer. Lancet 1999; 353: 391–399.
- Glimelius B, Hoffman K, Graf W, Pahlman L, Sjoden PO. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Cancer 1994; 73: 556–562.
- Mayer RJ. Oral versus intravenous fluoropyrimidine for advanced colorectal: by either route, it's all the same. J Clin Onc 2001; 19: 4093–4096.
- Poon MA, O'Connell MJ, Wieand HS et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989; 7: 1407–1417.
- de Gramont A, Bosset JF, Milan C et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer. J Clin Oncol 1997; 15: 808–815.
- Giacchetti S, Perpoint B, Zidani R et al. Phase III multi-center randomized trial of oxaliplatin added to chronomodulat-ed fluorouracil-leucovorin as first -line treatment of metastatic colorectal cancer. J Clin Oncol 2000; 18: 136–147.
- Saltz LB, Cox JV, Blanke C et al. Irinotecan plus fluo-rouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000; 343: 905–914.
- de Gramont A, Figer A, Seymour M et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938–2947.
- Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002; 38 (7): 1023–1033
- Rossi S, Di Stasi M, Buscarini E et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995; 1: 73–81.